Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer Metastatic

Interventions: Drug: Lamivudine

First Posted Date: 2017-05-09

Last Posted Date: 2024-06-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 36

Registration Number: NCT03144804

Locations: 🇺🇸
Massachusetts general Hospital, Boston, Massachusetts, United States

Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma

Phase 2

Completed

Conditions: Glioblastoma

Interventions: Drug: Temozolomide
Drug: Bavituximab
Radiation: Radiation

First Posted Date: 2017-05-04

Last Posted Date: 2024-05-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 36

Registration Number: NCT03139916

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Massachusetts general Hospital, Boston, Massachusetts, United States

Oxytocin and Cognitive Control in Adult ADHD

Early Phase 1

Completed

Conditions: Attention Deficit/Hyperactivity Disorder

Interventions: Drug: Oxytocin nasal spray
Drug: Placebo nasal spray

First Posted Date: 2017-05-02

Last Posted Date: 2024-05-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 24

Registration Number: NCT03136263

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Neurocognitive Features of Patients With Treatment-Resistant Depression

Completed

Conditions: Treatment Resistant Depression

First Posted Date: 2017-04-28

Last Posted Date: 2020-03-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 13

Registration Number: NCT03134066

Evaluation of the Philips Lifeline CareSage Risk Assessment System

Not Applicable

Completed

Conditions: Multimorbidity

Interventions: Other: Lifeline CareSage Flagging

First Posted Date: 2017-04-24

Last Posted Date: 2020-09-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 370

Registration Number: NCT03126565

Locations: 🇺🇸
Partners Healthcare at Home, Waltham, Massachusetts, United States

Positive Psychology for Acute Coronary Syndrome Patients

Not Applicable

Completed

Conditions: ACS - Acute Coronary Syndrome

Interventions: Behavioral: Positive Psychology + Motivational Interviewing
Behavioral: Motivational Interviewing Health Education

First Posted Date: 2017-04-20

Last Posted Date: 2020-05-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 69

Registration Number: NCT03122184

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia

Phase 2

Completed

Conditions: AML

Interventions: Drug: Etoposide
Drug: Cytarabine
Drug: Lenalidomide
Drug: Mitoxantrone

First Posted Date: 2017-04-18

Last Posted Date: 2024-04-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 41

Registration Number: NCT03118466

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts general Hospital, Boston, Massachusetts, United States

Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)

Phase 1

Terminated

Conditions: Kallmann Syndrome
Hypogonadotropic Hypogonadism

Interventions: Drug: Anastrozole Pill
Drug: Testosterone
Drug: Placebo Oral Tablet

First Posted Date: 2017-04-18

Last Posted Date: 2017-04-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 7

Registration Number: NCT03118479

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety

Not Applicable

Completed

Conditions: Panic Disorder
Heart Failure
Generalized Anxiety Disorder
Depression
Acute Coronary Syndrome

Interventions: Behavioral: Collaborative Care

First Posted Date: 2017-04-18

Last Posted Date: 2024-05-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 290

Registration Number: NCT03118752

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Salem Hospital, Salem, Massachusetts, United States

Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid

Not Applicable

Completed

Conditions: Thyroid Nodule
Follicular Neoplasm

Interventions: Device: Shear-Wave Elastography

First Posted Date: 2017-04-10

Last Posted Date: 2017-05-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 35

Registration Number: NCT03106337

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy